An integrated biomarker panel for early computational prediction of dengue severity during the acute phase
Clinical Immunology · 2026-01 · 282 · 110642
DOI: 10.1016/j.clim.2025.110642 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Immunology, 2026-01. Verfasst von Josephine Diony Nanda und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, School of Medicine, College of Medicine, Taipei Medical University Taipei 110, Taiwan; Department of Paras…. Hauptthemen laut MEDLINE: Biomarkers, Dengue, Cytokines. Die Arbeit nennt 44 Literaturangaben. Gefördert von: National Science and Technology Council.
Abstract (Originalsprache)
Serum cytokines and chemokines play a pivotal role in dengue immunopathogenesis and may serve as biomarkers of disease severity. This study aimed to identify applicable blood biomarkers during the acute stage of infection to support early severity evaluation using Principal Component Analysis (PCA)-based feature integration. Ninety-two dengue patients were consecutively enrolled from hospital admissions with laboratory-confirmed dengue during the 2015-2017 epidemic. Only those with NS1-positive or PCR-positive cases were included in this study, spanning asymptomatic, symptomatic, and severe cases, which were assessed for hematological, viral, and cytokine/chemokine parameters. Key variables-platelet count, GPT, creatinine, NS1, NST, IL-18, RANTES, IL-6, IFN-α2, and IL-7-were incorporated into a Prediction Panel. Validation showed that several biomarker combinations achieved up to 90 % accuracy in distinguishing severity groups, while others reached ∼70 %. Principal component analysis further refined the panel, showing accuracy above 90 % when NS1 or NST were included (A-B: 92.1 %, A-C: up to 91.8 %). These findings highlight the potential of an integrated biomarker-based Prediction Panel for early and reliable assessment of dengue severity within the first week of illness.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology and Immunology, School of Medicine, College of Medicine, Taipei Medical University Taipei 110, Taiwan; Department of Parasitology, Faculty of Medicine, Public Health and Nursing, Universitas G…
- Center of Infectious Disease and Signalling Research, National Cheng Kung University, Tainan, Taiwan; Department of Paediatrics, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung Universi…
- Department of Clinical Pathology and Laboratory Medicine, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta 55281, Indonesia; Clinical Laboratory Installation, Dr. Sardjito Central Gene…
- Department of Microbiology and Immunology, School of Medicine, College of Medicine, Taipei Medical University Taipei 110, Taiwan.
- Department of Microbiology and Immunology, School of Medicine, College of Medicine, Taipei Medical University Taipei 110, Taiwan; Center of Infectious Disease and Signalling Research, National Cheng Kung University, Tai…
Förderung
- National Science and Technology Council
Zitieren
APA
Nanda, J. D., Ho, T. S., Satria, R. D., Wang, Y. T., Lai, C. H., Lin, Y. L., & Lin, C. F. (2026). An integrated biomarker panel for early computational prediction of dengue severity during the acute phase. Clinical Immunology, 282, 110642. https://doi.org/10.1016/j.clim.2025.110642
Vancouver
Nanda JD, Ho TS, Satria RD, Wang YT, Lai CH, Lin YL, et al. An integrated biomarker panel for early computational prediction of dengue severity during the acute phase. Clinical Immunology. 2026;282:110642. doi:10.1016/j.clim.2025.110642
BibTeX
@article{Nanda2026,
author = {Nanda, Josephine Diony and Ho, Tzong-Shiann and Satria, Rahmat Dani and Wang, Yung-Ting and Lai, Chun-Hao and Lin, Ya-Lan and Lin, Chiou-Feng},
title = {An integrated biomarker panel for early computational prediction of dengue severity during the acute phase},
journal = {Clinical Immunology},
year = {2026},
volume = {282},
pages = {110642},
doi = {10.1016/j.clim.2025.110642}
}
EUVIMED